Montana; John Gary
Patent Applications and Registrations
Patent applications and USPTO patent grants for Montana; John Gary.The latest application filed is for "quinoline derivative in crystal form".
Company Profile
7.34.31
- Montana; John Gary - Essex GB
- Montana; John Gary - Ashdon GB
- Montana; John Gary - Harlow GB
- Montana; John Gary - Hertfordshire GB
- Montana; John Gary - Cambridge GB
Patent Activity
| Patent | Date |
|---|---|
| Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,822,342 - Hynd , et al. November 3, 2 | 2020-11-03 |
| Quinoline derivative in crystal form Grant 10,626,089 - Daley , et al. | 2020-04-21 |
| Quinoline Derivative In Crystal Form App 20200017447 - Daley; Donald John ; et al. | 2020-01-16 |
| Crystal Of Quinoline Derivative App 20190276405 - Daley; Donald John ; et al. | 2019-09-12 |
| Thienopyrimidine derivatives as NIK inhibitors Grant 10,323,045 - Hynd , et al. | 2019-06-18 |
| New Pyrazolopyrimidine Derivatives As Nik Inhibitors App 20190169198 - HYND; George ; et al. | 2019-06-06 |
| Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,221,180 - Hynd , et al. | 2019-03-05 |
| New Thienopyrimidine Derivatives As Nik Inhibitors App 20180298032 - HYND; George ; et al. | 2018-10-18 |
| Compounds as NIK inhibitors Grant 10,005,776 - Hynd , et al. June 26, 2 | 2018-06-26 |
| 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Grant 10,005,773 - Hynd , et al. June 26, 2 | 2018-06-26 |
| 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors Grant 9,981,963 - Hynd , et al. May 29, 2 | 2018-05-29 |
| Pyrazole derivatives as NIK inhibitors Grant 9,981,962 - Hynd , et al. May 29, 2 | 2018-05-29 |
| New Pyrazole Derivatives As Nik Inhibitors App 20170334900 - HYND; George ; et al. | 2017-11-23 |
| 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer Grant 9,643,964 - Hynd , et al. May 9, 2 | 2017-05-09 |
| NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160257679 - HYND; George ; et al. | 2016-09-08 |
| NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160229851 - HYND; George ; et al. | 2016-08-11 |
| 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine Derivatives As Nik Inhibitors For The Treatment Of Cancer App 20160075699 - HYND; George ; et al. | 2016-03-17 |
| Indoles And Their Therapeutic Use App 20130225617 - Hynd; George ; et al. | 2013-08-29 |
| Indoles and their therapeutic use Grant 8,394,836 - Hynd , et al. March 12, 2 | 2013-03-12 |
| Quinolines and their therapeutic use Grant 8,394,830 - Montana , et al. March 12, 2 | 2013-03-12 |
| Quinolines and Their Therapeutic Use App 20120184579 - Montana; John Gary ; et al. | 2012-07-19 |
| Quinolines and their therapeutic use Grant 8,173,812 - Montana , et al. May 8, 2 | 2012-05-08 |
| Indoles and Their Therapeutic Use App 20110071175 - Hynd; George ; et al. | 2011-03-24 |
| Indoles Active on CRTH2 Receptor App 20110060026 - Hynd; George ; et al. | 2011-03-10 |
| Aza-benzothiophenyl compounds and methods of use Grant 7,893,085 - Savy , et al. February 22, 2 | 2011-02-22 |
| Quinolines and their therapeutic use Grant 7,858,640 - Cramp , et al. December 28, 2 | 2010-12-28 |
| Aza-indolyl compounds and methods of use Grant 7,855,216 - Goodacre , et al. December 21, 2 | 2010-12-21 |
| Quinoline Derivatives As Crth2 Receptor Ligands App 20100144786 - Cramp; Michael Colin ; et al. | 2010-06-10 |
| Quinolines and Their Therapeutic Use App 20100144787 - Montana; John Gary ; et al. | 2010-06-10 |
| Indolizine Acetic Acid Derivatives as CRTH2 Antagonists App 20100137300 - Hynd; George ; et al. | 2010-06-03 |
| Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor App 20100093751 - Hynd; George ; et al. | 2010-04-15 |
| Quinolines and Their Therapeutic Use App 20090156600 - Cramp; Michael Colin ; et al. | 2009-06-18 |
| Indolizine Derivatives as Ligands of the Crth2 Receptor App 20080306109 - Hynd; George ; et al. | 2008-12-11 |
| Aza-indolyl Compounds And Methods Of Use App 20080242655 - Goodacre; Simon Charles ; et al. | 2008-10-02 |
| Aza-benzofuranyl compounds and methods of use App 20080085886 - Savy; Pascal Pierre ; et al. | 2008-04-10 |
| AZA-benzothiophenyl compounds and methods of use App 20080081821 - Savy; Pascal Pierre ; et al. | 2008-04-03 |
| Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone) App 20060052344 - Montana; John Gary ; et al. | 2006-03-09 |
| Selective MMP inhibitors having reduced side-effects Grant 6,818,622 - Bird , et al. November 16, 2 | 2004-11-16 |
| Hydroxamic and carboxylic acid derivatives App 20040127717 - Montana, John Gary ; et al. | 2004-07-01 |
| Hydroxamic and carboxylic acid derivatives Grant 6,680,338 - Montana , et al. January 20, 2 | 2004-01-20 |
| Hydroxamic And Carboxylic Acid Derivatives App 20030236416 - Montana, John Gary ; et al. | 2003-12-25 |
| Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity App 20030207889 - Owen, David Alan ; et al. | 2003-11-06 |
| Heterocyclic compounds and their therapeutic use Grant 6,642,254 - Dyke , et al. November 4, 2 | 2003-11-04 |
| Heterocyclic compounds and their therapeutic use App 20020183358 - Dyke, Hazel Joan ; et al. | 2002-12-05 |
| Bicyclic aryl carboxamides and their therapeutic use App 20020094987 - Dyke, Hazel Joan ; et al. | 2002-07-18 |
| Heterocyclic compounds and their therapeutic use Grant 6,403,791 - Dyke , et al. June 11, 2 | 2002-06-11 |
| Selective MMP inhibitors having reduced side-effects App 20020035065 - Bird, John ; et al. | 2002-03-21 |
| Bicyclic aryl carboxamides and their therapeutic use Grant 6,353,010 - Dyke , et al. March 5, 2 | 2002-03-05 |
| Heterocyclic compounds and their therapeutic use App 20020022645 - Dyke, Hazel Joan ; et al. | 2002-02-21 |
| Heterocyclic compounds and their therapeutic use App 20010031777 - Dyke, Hazel Joan ; et al. | 2001-10-18 |
| Heterocyclic compounds and their therapeutic use App 20010025049 - Dyke, Hazel Joan ; et al. | 2001-09-27 |
| Tetrahydronapthalene derivatives and their therapeutic use Grant 6,133,240 - Taylor , et al. October 17, 2 | 2000-10-17 |
| Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity Grant 6,118,001 - Owen , et al. September 12, 2 | 2000-09-12 |
| Quinolines and their therapeutic use Grant 6,069,151 - Dyke , et al. May 30, 2 | 2000-05-30 |
| Peptidyl compounds Grant 6,048,841 - Baxter , et al. April 11, 2 | 2000-04-11 |
| Peptidyl compounds having MMP and TNF inhibitory activity Grant 5,955,435 - Baxter , et al. September 21, 1 | 1999-09-21 |
| Benzofuran carboxamides and their therapeutic use Grant 5,925,636 - Dyke , et al. July 20, 1 | 1999-07-20 |
| Quinolones and their therapeutic use Grant 5,891,878 - Beasley , et al. April 6, 1 | 1999-04-06 |
| Quinoline sulfonamides and their therapeutic use Grant 5,834,485 - Dyke , et al. November 10, 1 | 1998-11-10 |
| Quinoline carboxanides and their therapeutic use Grant 5,804,588 - Dyke , et al. September 8, 1 | 1998-09-08 |
| Benzofuran sulphonanmides Grant 5,773,467 - Dyke , et al. June 30, 1 | 1998-06-30 |
| Quinolones and their therapeutic use Grant 5,753,666 - Beasley , et al. May 19, 1 | 1998-05-19 |
| 3,4-disubstituted-phenylsulphonamides and their therapeutic use Grant 5,728,712 - Montana , et al. March 17, 1 | 1998-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 